{'fraction_non_alphanumeric': 0.03278688524590164, 'fraction_numerical': 0.011349306431273645, 'mean_word_length': 5.508196721311475, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Booster effect of canine distemper, canine parvovirus infection and infectious canine hepatitis combination vaccine in domesticated adult dogs

Domesticated adult dogs with antibody titer classified as below ‘high’ to one or more of canine distemper virus (CDV), canine parvovirus type‐2 (CPV‐2) and canine adenovirus type‐1 (CAdV‐1) were then given an additional inoculation, and the effectiveness of this booster evaluated 2 months later. Consequently, CDV and CAdV‐1 antibody titer experienced a significant increase, but the same effect was not observed in the antibody titer of CPV‐2. These findings suggest that with additional inoculation, a booster effect may be expected in increasing antibody titers for CDV and CAdV‐1, but it is unlikely to give an increase in CPV‐2 antibody titer.